New Transplant Technology Not Science Fiction
Submitted by admin on Mon, 10/03/2011 - 08:47
David Green, president of Harvard BioScience, discusses the future of transplant technology and regenerative medicine.
Source: TheStreet.com
Market Data
View & Download
Recent News
- HBIO Reports First Quarter 2012 Revenue Growth of 8% Over First Quarter 2011
- Harvard Bioscience, Inc. Schedules First Quarter 2012 Conference Call for May 3, 2012
- Harvard Bioscience Comments on the Passing of Christopher Lyles
- HBIO Reports Fourth Quarter 2011 Results
- Harvard Bioscience, Inc. Schedules Fourth Quarter 2011 Conference Call for March 1, 2012
- Harvard Bioscience, Inc. Acquires AHN
- News In Brief: Biomedical Briefing
- Harvard Bioscience, Inc. Announces Participation in the Regenerative Medicine Insight Track at the Biotech Showcase
- Mass. Company Behind World’s First Artificial Trachea Transplant
- Vermont Ballerina Needs Life-Saving Surgery
- Harvard Bioscience's "InBreath" Bioreactor Used in World's Second Successful Synthetic Trachea Transplant
- Harvard Bioscience's InBreath Bioreactor Highlighted in Article in The Lancet Summarizing the World's First Synthetic Trachea Transplant
- Harvard Bioscience, Inc. Schedules Third Quarter 2011 Conference Call for November 3, 2011
- Stem Cell Innovation Saves Lives
- World's First Artificial Windpipe Transplant May Open The Door To More Procedures
Contacts & RSS
Investor Relations
Adam Holdsworth
Phone
212.825.3210
Subscribe to Harvard Bioscience, Inc. news, video, and more.
